Glenmark Life Sciences Ltd IPO

Glenmark Life Sciences Ltd IPO to opens from 27 July, 2021, at price band of  ₹695 - ₹720/Share.

Issue closes on 29th July, 2021.

The Glenmark Life Sciences IPO's market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (total 260 shares at ₹187,200).

Glenmark Life Sciences Ltd IPO Details

Glenmark Life IPO Tentative Timetable

Share allotment of the issue is expected to get finalized on 3rd August, 2021.

Glenmark Life Sciences ltd incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.